Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

Appell, R A

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. [electronic resource] - Mayo Clinic proceedings Apr 2001 - 358-63 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0025-6196


Aged
Benzhydryl Compounds--administration & dosage
Cresols--administration & dosage
Delayed-Action Preparations
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Mandelic Acids--administration & dosage
Middle Aged
Muscarinic Antagonists--administration & dosage
Nervous System Diseases--chemically induced
Phenylpropanolamine
Probability
Prospective Studies
Reference Values
Severity of Illness Index
Statistics, Nonparametric
Tartrates--administration & dosage
Tolterodine Tartrate
Treatment Outcome
Urinary Bladder, Neurogenic--complications
Urinary Incontinence, Stress--diagnosis
Urination Disorders--diagnosis
Xerostomia--chemically induced